HIGHLIGHTS
- who: Tianyi Zhu from the Fudan University, China have published the research work: Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications, in the Journal: (JOURNAL)
- what: The studies mentioned above also focused on the pro-tumor activity of DCs, which is a vital risk when using DCassociated therapy. The research above is far from sufficient for the following reasons.
- how: The results showed that hypermethylation in the fragment crystallizable region of immunoglobulin (Ig) E high-affinity I receptor for g polypeptide was significantly associated with osteosarcoma development.
- future: It . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.